Analysts have clear opinions on CDXS.

There are 2 analysts on the Wall offering 12 month price targets for Codexis in the last 3 months. The average price target is $22.50 with a high forecast of $22.50 and a low forecast of $22.50. The average price target represents a 146.71% increase from the last price of $9.12.
Codexis, Inc. (CDXS) is followed by 2 analysts on the street.

null from rates it a .

Similarly, null of a with a target of .

The consensus on the street is null.

What does Codexis, Inc.(CDXS) do ?
Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Codexis, Inc. (CDXS) Insider Trades

Multiple company employees have indulged in significant insider trading. Codexis, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

Dir, Dorgan Byron L : S – Sale(-$234,192) of CDXS in the trading session of 2020-02-21.

Dir Kelley Bernard J : S – Sale(-$45,000) of CDXS in the trading session of 2020-01-21.

Dir Baruch Thomas R : S – Sale(-$372,906) of Codexis, Inc. in the trading session of 2020-01-15.

Looking for stocks just like CDXS?

Based on Wall Street analyst research, several stocks are similar to CDXS
They are:
– MRK [Info can be found here: https://www.nasdaq.com/market-activity/stocks/MRK ]
– GSK [Info can be found here: https://www.nasdaq.com/market-activity/stocks/GSK ]
– PFE [Info can be found here: https://www.nasdaq.com/market-activity/stocks/PFE ]